The US investment fund Warburg Pincus has announced its intention to buy a majority stake in the Slovak drugs maker Slovakofarma through the target's 61% majority shareholder SL Pharma. The move will cut out the need for a public offer.
SL Pharma officials said that following a due diligence and further negotiations between the two companies the deal could be closed by the end of the first half of 2002.
17. Dec 2001 at 0:00 | From press reports of TASR and SITA